Holders — by stockHoldings — by fund
General Catalyst Group Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1637946
$188.5M
disclosed book value
14
positions
27.5%
largest position share
Positions, as of 2026-06-30
top 14 of 14 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | AVBPArriVent BioPharma, Inc. | 1.5M | $51.9M | 27.5% |
| 2 | PBLSParabilis Medicines, Inc. | 1.6M | $43.8M | 23.2% |
| 3 | CARTMaplebear, Inc. | 710,711 | $33.7M | 17.9% |
| 4 | MAZEMaze Therapeutics, Inc. | 1.0M | $30.9M | 16.4% |
| 5 | ODTXOdyssey Therapeutics, Inc. | 810,272 | $15.2M | 8% |
| 6 | EIKNEikon Therapeutics, Inc. | 305,233 | $4.0M | 2.1% |
| 7 | GUTSFractyl Health, Inc. | 4.9M | $3.9M | 2.1% |
| 8 | LIFEEthos Technologies, Inc. | 74,179 | $1.3M | 0.7% |
| 9 | CPNGCoupang Inc. | 54,677 | $949,739 | 0.5% |
| 10 | AMZNAmazon.com Inc. | 3,882 | $925,236 | 0.5% |
| 11 | METAMeta Platforms Inc. | 1,320 | $743,543 | 0.4% |
| 12 | DASHDoordash Inc. | 2,850 | $525,911 | 0.3% |
| 13 | CVNACarvana Co | 6,465 | $425,526 | 0.2% |
| 14 | FIGFigma, Inc. | 14,845 | $268,546 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.